Myristoyl‐CoA: protein N‐myristoyltransferase activity in cancer cells
Open Access
- 1 June 1993
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 214 (3) , 853-867
- https://doi.org/10.1111/j.1432-1033.1993.tb17989.x
Abstract
Myristoylation is a co-translational maturation process of proteins. It is extremely specific for the cosubstrate (myristoyl-CoA) and for the substrate protein that should bear a glycine at the N-terminus of the protein to be myristoylated. This acylation is catalyzed by the myristoyl-CoA:protein N-myristoyltransferase. Most of the molecular biochemistry and biology concerning this enzyme has been done on Saccharomyces cerevisiae. Because of the major importance of this pathway in several types of pathology, it is essential to study intensively the enzyme(s) isolated from mammalian tissue(s) to confirm that the enormous amount of work done on the yeast enzyme can be transposed to mammalian tissues. In earlier studies, we demonstrated the existence of a microsomal N-myristoyltransferase from the murine leukemia cell line L1210 [Boutin, J. A., Clarenc, J.-P., Ferry, G., Ernould, A. P., Remond, G., Vincent, M. & Atassi, G. (1991) Eur. J. Biochem. 201, 257-263], a feature which is not shared by yeast, and examined the N-myristoyltransferase activities associated with L1210 cytosol. In the present work, we purified to homogeneity one of the isoforms (A) of the transferase from L1210 cytosol. The purified enzyme showed on SDS/PAGE an apparent molecular mass of 67.5 kDa, distinct from the 53-kDa yeast cytosolic enzyme. The purified enzyme from L1210 cytosol could be labeled with [14C]myristoyl-CoA. Rabbit antibodies were raised against the A isoform and used to immunoprecipitate the enzyme and immunoinhibit the activity from the same source. A survey of the specificity of the partially and completely purified isoforms was performed using peptides derived from the NH2-terminus of 42 proteins which are potential substrates for myristoylation, including oncogene products and virus structural proteins. We synthesized a series of compounds capable of inhibiting the cytosol activities of the enzyme. For example, a myristoyltetrahydroquinolein derivative showed an IC50 of about 0.1 microM. Based on both biophysical and biochemical evidence, the N-myristoyltransferases extracted from mammalian cell cytosols seem to be different from the extensively studied yeast enzyme.Keywords
This publication has 67 references indexed in Scilit:
- Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetiiCellular Microbiology, 2007
- Elevated N-myristoyl transferase activity is reversed by sodium orthovanadate in streptozotocin-induced diabetic ratBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteinsBiochemistry, 1991
- Fatty acylated proteins as components of intracellular signaling pathwaysBiochemistry, 1990
- Characterisation of a Myristoyl CoA:Glycylpeptide N‐Myristoyl Transferase Activity in Rat Brain: Subcellular and Regional DistributionJournal of Neurochemistry, 1990
- New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral ActivityJNCI Journal of the National Cancer Institute, 1989
- Activation of the Cellular Proto-Oncogene Product p21Ras by Addition of a Myristylation SignalScience, 1989
- 12‐O‐Tetradecanoyl phorbol 13‐acetate stimulates the myristylation of an ∼ 82 kDa protein in HL‐60 cellsFEBS Letters, 1987
- Identification of the NH2‐terminal blocking group of calcineurin B as myristic acidFEBS Letters, 1982
- Characterization of membrane proteins in detergent solutionsBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1976